SEC Stock Data Quick Answer ZIMMER BIOMET HOLDINGS, INC. reported Gross Profit of $3.42 billion for fiscal year 2014. ZIMMER BIOMET HOLDINGS, INC. Gross Profit — Annual History Fiscal Year Gross Profit YoY Change 2014 $3.42B +2.6% 2013 $3.34B -0.3% 2012 $3.35B +0.5% 2011 $3.33B +3.8% 2010 $3.21B +3.3% 2009 $3.10B -0.6% 2008 $3.12B +3.4% 2007 $3.02B — … Read more
Quick Answer ZIMMER BIOMET HOLDINGS, INC. reported Operating Income of $1.10 billion for fiscal year 2025. ZIMMER BIOMET HOLDINGS, INC. Operating Income — Annual History Fiscal Year Operating Income YoY Change 2025 $1.10B -14.6% 2024 $1.29B +0.6% 2023 $1.28B +83.5% 2022 $696.30M -19.1% 2021 $860.30M +935.3% 2020 $83.10M -92.7% 2019 $1.14B +3265.4% 2018 $33.80M -95.8% … Read more
Quick Answer ZIMMER BIOMET HOLDINGS, INC. reported R&D Expense of $225.60 million for fiscal year 2012. ZIMMER BIOMET HOLDINGS, INC. R&D Expense — Annual History Fiscal Year R&D Expense YoY Change 2012 $225.60M -5.4% 2011 $238.40M +9.1% 2010 $218.50M — Quarterly R&D Expense Quarter Ending R&D Expense YoY QoQ March 31, 2013 $53.50M -10.2% +0.0% … Read more
Quick Answer ZIMMER BIOMET HOLDINGS, INC. reported Stockholders Equity of $12.70 billion for fiscal year 2025. ZIMMER BIOMET HOLDINGS, INC. Stockholders Equity — Annual History Fiscal Year Stockholders Equity YoY Change 2025 $12.70B +1.8% 2024 $12.47B -0.1% 2023 $12.48B +3.8% 2022 $12.02B -5.1% 2021 $12.66B +3.8% 2020 $12.19B -1.6% 2019 $12.39B +9.9% 2018 $11.27B -4.0% … Read more
Quick Answer ZIMMER BIOMET HOLDINGS, INC. reported Long-Term Debt of $6.93 billion for fiscal year 2025. ZIMMER BIOMET HOLDINGS, INC. Long-Term Debt — Annual History Fiscal Year Long-Term Debt YoY Change 2025 $6.93B +29.8% 2024 $5.34B +9.7% 2023 $4.87B -5.5% 2022 $5.15B -5.7% 2021 $5.46B -28.4% 2020 $7.63B +13.5% 2019 $6.72B -20.1% 2018 $8.41B -5.6% … Read more
Quick Answer ZIMMER BIOMET HOLDINGS, INC. reported Cash and Equivalents of $591.90 million for fiscal year 2025. ZIMMER BIOMET HOLDINGS, INC. Cash and Equivalents — Annual History Fiscal Year Cash and Equivalents YoY Change 2025 $591.90M +12.6% 2024 $525.50M +26.4% 2023 $415.80M +10.7% 2022 $375.70M -0.6% 2021 $378.10M -52.9% 2020 $802.10M +29.8% 2019 $617.90M +13.8% … Read more
Quick Answer ZIMMER BIOMET HOLDINGS, INC. reported Total Assets of $23.09 billion for fiscal year 2025. ZIMMER BIOMET HOLDINGS, INC. Total Assets — Annual History Fiscal Year Total Assets YoY Change 2025 $23.09B +8.1% 2024 $21.37B -0.6% 2023 $21.50B +2.0% 2022 $21.07B -10.2% 2021 $23.46B -3.9% 2020 $24.42B -0.9% 2019 $24.64B +2.1% 2018 $24.13B -7.3% … Read more
Quick Answer ZIMMER BIOMET HOLDINGS, INC. reported Diluted EPS of $3.55 per share for fiscal year 2025. ZIMMER BIOMET HOLDINGS, INC. Diluted EPS — Annual History Fiscal Year Diluted EPS YoY Change 2025 $3.55 -19.9% 2024 $4.43 -9.2% 2023 $4.88 +343.6% 2022 $1.10 -42.4% 2021 $1.91 +385.1% 2020 -$0.67 -112.2% 2019 $5.47 +394.1% 2018 -$1.86 … Read more
Quick Answer ZIMMER BIOMET HOLDINGS, INC. reported Net Income of $705.10 million for fiscal year 2025. ZIMMER BIOMET HOLDINGS, INC. Net Income — Annual History Fiscal Year Net Income YoY Change 2025 $705.10M -22.0% 2024 $903.80M -11.7% 2023 $1.02B +342.5% 2022 $231.40M -42.4% 2021 $401.60M +389.1% 2020 -$138.90M -112.3% 2019 $1.13B +398.4% 2018 -$379.20M -120.9% … Read more
Quick Answer ZIMMER BIOMET HOLDINGS, INC. reported Revenue (ASC 606) of $8.23 billion for fiscal year 2025. ZIMMER BIOMET HOLDINGS, INC. Revenue (ASC 606) — Annual History Fiscal Year Revenue (ASC 606) YoY Change 2025 $8.23B +7.2% 2024 $7.68B +3.8% 2023 $7.39B +6.5% 2022 $6.94B +1.6% 2021 $6.83B +11.4% 2020 $6.13B -23.2% 2019 $7.98B +0.6% … Read more